Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group

<p>Abstract</p> <p>Background</p> <p>To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovascul...

Full description

Bibliographic Details
Main Authors: Gomes Marília B, Cobas Roberta A, Matheus Alessandra S, Tannus Lucianne R, Negrato Carlos, Rodacki Melanie, Braga Neuza, Cordeiro Marilena M, Luescher Jorge L, Berardo Renata S, Nery Marcia, Marques MariadoCarmo A, Calliari Luiz E, Noronha Renata M, Manna Thais D, Zajdenverg Lenita, Salvodelli Roberta, Penha Fernanda G, Foss Milton C, Foss-Freitas Maria C, Pires Antonio C, Robles Fernando C, Guedes MariadeFátimaS, Dib Sergio A, Dualib Patricia, Silva Saulo C, Sepulvida Janice, Almeida Henriqueta G, Sampaio Emerson, Rea Rosangela, Faria Ana Cristina R, Tschiedel Balduino, Lavigne Suzana, Cardozo Gustavo A, Azevedo Mirela J, Canani Luis, Zucatti Alessandra T, Coral Marisa Helena C, Pereira Daniela, Araujo Luiz, Tolentino Monica, Pedrosa Hermelinda C, Prado Flaviane A, Rassi Nelson, Araujo Leticia B, Fonseca Reine Marie C, Guedes Alexis D, Matos Odelissa S, Faria Manuel, Azulay Rossana, Forti Adriana C, Façanha Cristina, Montenegro Ana, Montenegro Renan, Melo Naira H, Rezende Karla F, Ramos Alberto, Felicio João, Santos Flavia M, Jezini Deborah L
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:http://www.dmsjournal.com/content/4/1/44
id doaj-e7ce7ed5ac2c49a0887bc1e80e5633de
record_format Article
spelling doaj-e7ce7ed5ac2c49a0887bc1e80e5633de2020-11-24T21:35:38ZengBMCDiabetology & Metabolic Syndrome1758-59962012-10-01414410.1186/1758-5996-4-44Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study GroupGomes Marília BCobas Roberta AMatheus Alessandra STannus Lucianne RNegrato CarlosRodacki MelanieBraga NeuzaCordeiro Marilena MLuescher Jorge LBerardo Renata SNery MarciaMarques MariadoCarmo ACalliari Luiz ENoronha Renata MManna Thais DZajdenverg LenitaSalvodelli RobertaPenha Fernanda GFoss Milton CFoss-Freitas Maria CPires Antonio CRobles Fernando CGuedes MariadeFátimaSDib Sergio ADualib PatriciaSilva Saulo CSepulvida JaniceAlmeida Henriqueta GSampaio EmersonRea RosangelaFaria Ana Cristina RTschiedel BalduinoLavigne SuzanaCardozo Gustavo AAzevedo Mirela JCanani LuisZucatti Alessandra TCoral Marisa Helena CPereira DanielaAraujo LuizTolentino MonicaPedrosa Hermelinda CPrado Flaviane ARassi NelsonAraujo Leticia BFonseca Reine Marie CGuedes Alexis DMatos Odelissa SFaria ManuelAzulay RossanaForti Adriana CFaçanha CristinaMontenegro AnaMontenegro RenanMelo Naira HRezende Karla FRamos AlbertoFelicio JoãoSantos Flavia MJezini Deborah LCordeiro Marilena M<p>Abstract</p> <p>Background</p> <p>To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovascular risk factors, screening for chronic complications and the frequency that the recommended treatment goals were met using the American Diabetes Association guidelines were evaluated<b>.</b></p> <p>Methods</p> <p>This was a cross-sectional, multicenter study conducted from December 2008 to December 2010 in 28 secondary and tertiary care public clinics in 20 Brazilian cities in north/northeast, mid-west, southeast and south regions. The data were obtained from 3,591 patients (56.0% females and 57.1% Caucasians) aged 21.2 ± 11.7 years with a disease duration of 9.6 ± 8.1 years (<1 to 50 years).</p> <p>Results</p> <p>Overall, 18.4% patients had HbA1c levels <7.0%, and 47.5% patients had HbA1c levels ≥ 9%. HbA1c levels were associated with lower economic status, female gender, age and the daily frequency of self-blood glucose monitoring (SBGM) but not with insulin regimen and geographic region. Hypertension was more frequent in the mid-west (32%) and north/northeast (25%) than in the southeast (19%) and south (17%) regions (p<0.001). More patients from the southeast region achieved LDL cholesterol goals and were treated with statins (p<0.001). Fewer patients from the north/northeast and mid-west regions were screened for retinopathy and nephropathy, compared with patients from the south and southeast. Patients from the south/southeast regions had more intensive insulin regimens than patients from the north/northeast and mid-west regions (p<0.001). The most common insulin therapy combination was intermediate-acting with regular human insulin, mainly in the north/northeast region (p<0.001). The combination of insulin glargine with lispro and glulisine was more frequently used in the mid-west region (p<0.001). Patients from the north/northeast region were younger, non-Caucasian, from lower economic status, used less continuous subcutaneous insulin infusion, performed less SBGM and were less overweight/obese (p<0.001).</p> <p>Conclusions</p> <p>A majority of patients, mainly in the north/northeast and mid-west regions, did not meet metabolic control goals and were not screened for diabetes-related chronic complications. These results should guide governmental health policy decisions, specific to each geographic region, to improve diabetes care and decrease the negative impact diabetes has on the public health system.</p> http://www.dmsjournal.com/content/4/1/44Type 1 diabetesGlycemic controlCardiovascular risk factorsChronic complicationsEconomic status
collection DOAJ
language English
format Article
sources DOAJ
author Gomes Marília B
Cobas Roberta A
Matheus Alessandra S
Tannus Lucianne R
Negrato Carlos
Rodacki Melanie
Braga Neuza
Cordeiro Marilena M
Luescher Jorge L
Berardo Renata S
Nery Marcia
Marques MariadoCarmo A
Calliari Luiz E
Noronha Renata M
Manna Thais D
Zajdenverg Lenita
Salvodelli Roberta
Penha Fernanda G
Foss Milton C
Foss-Freitas Maria C
Pires Antonio C
Robles Fernando C
Guedes MariadeFátimaS
Dib Sergio A
Dualib Patricia
Silva Saulo C
Sepulvida Janice
Almeida Henriqueta G
Sampaio Emerson
Rea Rosangela
Faria Ana Cristina R
Tschiedel Balduino
Lavigne Suzana
Cardozo Gustavo A
Azevedo Mirela J
Canani Luis
Zucatti Alessandra T
Coral Marisa Helena C
Pereira Daniela
Araujo Luiz
Tolentino Monica
Pedrosa Hermelinda C
Prado Flaviane A
Rassi Nelson
Araujo Leticia B
Fonseca Reine Marie C
Guedes Alexis D
Matos Odelissa S
Faria Manuel
Azulay Rossana
Forti Adriana C
Façanha Cristina
Montenegro Ana
Montenegro Renan
Melo Naira H
Rezende Karla F
Ramos Alberto
Felicio João
Santos Flavia M
Jezini Deborah L
Cordeiro Marilena M
spellingShingle Gomes Marília B
Cobas Roberta A
Matheus Alessandra S
Tannus Lucianne R
Negrato Carlos
Rodacki Melanie
Braga Neuza
Cordeiro Marilena M
Luescher Jorge L
Berardo Renata S
Nery Marcia
Marques MariadoCarmo A
Calliari Luiz E
Noronha Renata M
Manna Thais D
Zajdenverg Lenita
Salvodelli Roberta
Penha Fernanda G
Foss Milton C
Foss-Freitas Maria C
Pires Antonio C
Robles Fernando C
Guedes MariadeFátimaS
Dib Sergio A
Dualib Patricia
Silva Saulo C
Sepulvida Janice
Almeida Henriqueta G
Sampaio Emerson
Rea Rosangela
Faria Ana Cristina R
Tschiedel Balduino
Lavigne Suzana
Cardozo Gustavo A
Azevedo Mirela J
Canani Luis
Zucatti Alessandra T
Coral Marisa Helena C
Pereira Daniela
Araujo Luiz
Tolentino Monica
Pedrosa Hermelinda C
Prado Flaviane A
Rassi Nelson
Araujo Leticia B
Fonseca Reine Marie C
Guedes Alexis D
Matos Odelissa S
Faria Manuel
Azulay Rossana
Forti Adriana C
Façanha Cristina
Montenegro Ana
Montenegro Renan
Melo Naira H
Rezende Karla F
Ramos Alberto
Felicio João
Santos Flavia M
Jezini Deborah L
Cordeiro Marilena M
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
Diabetology & Metabolic Syndrome
Type 1 diabetes
Glycemic control
Cardiovascular risk factors
Chronic complications
Economic status
author_facet Gomes Marília B
Cobas Roberta A
Matheus Alessandra S
Tannus Lucianne R
Negrato Carlos
Rodacki Melanie
Braga Neuza
Cordeiro Marilena M
Luescher Jorge L
Berardo Renata S
Nery Marcia
Marques MariadoCarmo A
Calliari Luiz E
Noronha Renata M
Manna Thais D
Zajdenverg Lenita
Salvodelli Roberta
Penha Fernanda G
Foss Milton C
Foss-Freitas Maria C
Pires Antonio C
Robles Fernando C
Guedes MariadeFátimaS
Dib Sergio A
Dualib Patricia
Silva Saulo C
Sepulvida Janice
Almeida Henriqueta G
Sampaio Emerson
Rea Rosangela
Faria Ana Cristina R
Tschiedel Balduino
Lavigne Suzana
Cardozo Gustavo A
Azevedo Mirela J
Canani Luis
Zucatti Alessandra T
Coral Marisa Helena C
Pereira Daniela
Araujo Luiz
Tolentino Monica
Pedrosa Hermelinda C
Prado Flaviane A
Rassi Nelson
Araujo Leticia B
Fonseca Reine Marie C
Guedes Alexis D
Matos Odelissa S
Faria Manuel
Azulay Rossana
Forti Adriana C
Façanha Cristina
Montenegro Ana
Montenegro Renan
Melo Naira H
Rezende Karla F
Ramos Alberto
Felicio João
Santos Flavia M
Jezini Deborah L
Cordeiro Marilena M
author_sort Gomes Marília B
title Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
title_short Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
title_full Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
title_fullStr Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
title_full_unstemmed Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
title_sort regional differences in clinical care among patients with type 1 diabetes in brazil: brazilian type 1 diabetes study group
publisher BMC
series Diabetology & Metabolic Syndrome
issn 1758-5996
publishDate 2012-10-01
description <p>Abstract</p> <p>Background</p> <p>To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovascular risk factors, screening for chronic complications and the frequency that the recommended treatment goals were met using the American Diabetes Association guidelines were evaluated<b>.</b></p> <p>Methods</p> <p>This was a cross-sectional, multicenter study conducted from December 2008 to December 2010 in 28 secondary and tertiary care public clinics in 20 Brazilian cities in north/northeast, mid-west, southeast and south regions. The data were obtained from 3,591 patients (56.0% females and 57.1% Caucasians) aged 21.2 ± 11.7 years with a disease duration of 9.6 ± 8.1 years (<1 to 50 years).</p> <p>Results</p> <p>Overall, 18.4% patients had HbA1c levels <7.0%, and 47.5% patients had HbA1c levels ≥ 9%. HbA1c levels were associated with lower economic status, female gender, age and the daily frequency of self-blood glucose monitoring (SBGM) but not with insulin regimen and geographic region. Hypertension was more frequent in the mid-west (32%) and north/northeast (25%) than in the southeast (19%) and south (17%) regions (p<0.001). More patients from the southeast region achieved LDL cholesterol goals and were treated with statins (p<0.001). Fewer patients from the north/northeast and mid-west regions were screened for retinopathy and nephropathy, compared with patients from the south and southeast. Patients from the south/southeast regions had more intensive insulin regimens than patients from the north/northeast and mid-west regions (p<0.001). The most common insulin therapy combination was intermediate-acting with regular human insulin, mainly in the north/northeast region (p<0.001). The combination of insulin glargine with lispro and glulisine was more frequently used in the mid-west region (p<0.001). Patients from the north/northeast region were younger, non-Caucasian, from lower economic status, used less continuous subcutaneous insulin infusion, performed less SBGM and were less overweight/obese (p<0.001).</p> <p>Conclusions</p> <p>A majority of patients, mainly in the north/northeast and mid-west regions, did not meet metabolic control goals and were not screened for diabetes-related chronic complications. These results should guide governmental health policy decisions, specific to each geographic region, to improve diabetes care and decrease the negative impact diabetes has on the public health system.</p>
topic Type 1 diabetes
Glycemic control
Cardiovascular risk factors
Chronic complications
Economic status
url http://www.dmsjournal.com/content/4/1/44
work_keys_str_mv AT gomesmariliab regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT cobasrobertaa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT matheusalessandras regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT tannuslucianner regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT negratocarlos regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT rodackimelanie regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT braganeuza regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT cordeiromarilenam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT luescherjorgel regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT berardorenatas regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT nerymarcia regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT marquesmariadocarmoa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT calliariluize regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT noronharenatam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT mannathaisd regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT zajdenverglenita regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT salvodelliroberta regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT penhafernandag regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT fossmiltonc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT fossfreitasmariac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT piresantonioc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT roblesfernandoc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT guedesmariadefatimas regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT dibsergioa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT dualibpatricia regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT silvasauloc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT sepulvidajanice regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT almeidahenriquetag regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT sampaioemerson regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT rearosangela regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT fariaanacristinar regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT tschiedelbalduino regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT lavignesuzana regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT cardozogustavoa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT azevedomirelaj regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT cananiluis regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT zucattialessandrat regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT coralmarisahelenac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT pereiradaniela regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT araujoluiz regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT tolentinomonica regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT pedrosahermelindac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT pradoflavianea regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT rassinelson regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT araujoleticiab regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT fonsecareinemariec regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT guedesalexisd regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT matosodelissas regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT fariamanuel regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT azulayrossana regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT fortiadrianac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT facanhacristina regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT montenegroana regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT montenegrorenan regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT melonairah regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT rezendekarlaf regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT ramosalberto regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT feliciojoao regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT santosflaviam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT jezinideborahl regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
AT cordeiromarilenam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup
_version_ 1725944755920044032